L10: drugs in the management of musculoskeletal disorders Flashcards

1
Q

iatrogenic=

A

relating to illness caused by medical examination or treatment

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

osteoblast=

A

cell that makes bone

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

osteoclast=

A

a multinucleate cell that breaks down bone

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

pharmacokinetics=

A

the process by which a drug is absorbed, distributed, metabolised and eliminated

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

outer shell of bone=

A

cortical bone

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

inner bone=

A

trabecular mesh

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

osteoporosis =

A

thinning of bone

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

most commonly affected bones in osteoporosis (3)

A

wrist
hip
spine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

osteoclasts sit in

A

Howship lacunae

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

how do osteoclasts form

A

formed by fusion of many cells derived from monocytes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

how do osteoblasts form

A

differentiation of osteogenic cells in the periosteum

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

how do osteoblasts and osteoclasts communicate

A

cytokines

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

what do osteoblasts produce

A

RANKL

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

what does RANK L do

A

binds to RANK receptor on the osteoclast precursor cell to initiate maturation of the osteoclast

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

what produces OPG

A

osteoblasts and stromal cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

what is OPG

A

a soluble ligand which mops up the RANK L so it can no longer act as a signal

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

when osteoclasts bind to bone what do they form

A

a celling zone

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

what mineral is released when bone is broken down

A

calcium

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

what are bisphosphonates

A

enzyme-resistant analogues of pyrophosphate (which normally inhibits mineralization of bone)

20
Q

how do BPs work

A

decrease osteoclast activity by decreasing osteoclast progenitor development + increase osteoclast apoptosis

21
Q

what binding sites do BPs attach to

A

hydroxyapatite

22
Q

2 types of BPs

A
  • non nitrogen containing

- nitrogen containing

23
Q

e.g of Non-N containing BP

A

Etidronate

24
Q

e.g of nitrogen containing BP

A

alendronate

25
Q

widest adverse effect of BP therapy

A

osteonecrosis of the jaw

26
Q

SERM=

A

selective estrogen receptor modulator

27
Q

e.g of SERM

A

raloxifene

28
Q

SERM used for breast cancer

A

Tamoxifen

29
Q

HRT that increase risk in 2 types of breast cancer

A

breast cancer

ovarian cancer

30
Q

where is calcitonin released from

A

thyroid

31
Q

what does calcitonin do (3)

A
  1. increases osteoblast activity
  2. decrease intestine Ca2+ absorption
  3. Decrease Ca2+ renal absorption
32
Q

what does PTH do

A

increase osteoclast activity

33
Q

4 ways to target Rheumatoid arthritis

A

NSAIDs
Steroids
DMARDs
Biological agents

34
Q

used for severe RA

A

immunosuppression

35
Q

COX-2=

A

inflammation

36
Q

COX-1=

A
  • gastrointestinal tract
  • renal tract
  • platelet function
  • macrophage differentiation
37
Q

steroidal anti-inflammatory drugs target ____ to decrease

A

nuclear receptors to decrease expression of inflammatory cytokines

38
Q

e.g of a SAID

A

prednisolone

39
Q

what gland shrinks when patients are on steroids

A

adrenal gland

40
Q

DMARDs=

A

disease modifying anti-rheumatic drugs

41
Q

what do DMARDs do

A

reduce damage to joints

42
Q

3 DMARDS

A
  • hydroxychloroquine
  • methotrexate
  • sulfasalazine
43
Q

MOA of methotrexate

A

affects dihydrofolate reductase

44
Q

what are biological therapies based on

A

monoclonal antibodies

45
Q

3 biological therapies

A

adalimumab
etanercept
infliximab

46
Q

what do adalimumab, etanercept and infliximab all target

A

tumour necrosis factor alpha

47
Q

immunosuppressant agent of last resort

A

ciclosporin